MUMBAI Drugmaker Claris Lifesciences Ltd (CLAI.BO) said on Friday it will form a joint venture with Japan's Otsuka Pharmaceutical Factory and Mitsui & Co Ltd (8031.T) for its medical infusion drugs business in India and emerging countries.
Claris said its board also approved the sale of its infusion business, on a slump basis, to the company's fully-owned unit, Claris Speciality Injectables, which will eventually run the joint venture.
(Reporting by Kaustubh Kulkarni in MUMBAI)
Asia stocks hold gains before Yellen speech, dollar firm
HONG KONG Asian stocks edged higher on Thursday but clung to recent well-worn trading ranges while the dollar held firm against regional currencies ahead of a speech by Federal Reserve Chair Janet Yellen at a global central bankers' meeting.
EXCLUSIVE: Monsanto pulls new GM cotton seed from India in protest
NEW DELHI Monsanto Co has withdrawn an application seeking approval for its next generation of genetically modified cotton seeds in India, a major escalation in a long-running dispute between New Delhi and the world's biggest seed maker.
Welspun faces new probe from Bed Bath, shares pressured
CHICAGO/NEW DELHI U.S. retailer Bed Bath & Beyond said it ordered an external audit of textiles from Welspun India, putting more pressure on the embattled Indian bedding and towel maker that has seen nearly half its market value wiped out this week.